Schedule Update - effective 1 January 2010 (text extract)

This is the text extract for Schedule Update - effective 1 January 2010 , browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 January 2010 Section H cumulative for December 2009 and January 2010

Contents

Summary of PHARMAC decisions effective 1 January 2010 ........................... 3 Solifenacin succinate tablets– new listing ..................................................... 5 Mesalazine 500 mg enteric coated tablets – new listing ............................... 5 Silver sulphadiazine (Flamazine) 1% cream – new listing .............................. 5 Fosamax Plus ................................................................................................. 6 New risperidone and topiramate listings – update ........................................ 6 Colifoam – clarification of dose ..................................................................... 7 Depo-Provera – glass vial delisting ................................................................ 7 Tender News .................................................................................................. 8 Looking Forward ........................................................................................... 8 Sole Subsidised Supply products cumulative to January 2010 ..................... 10 New Listings ................................................................................................ 18 Changes to Restrictions ............................................................................... 19 Changes to Subsidy and Manufacturer’s Price............................................. 20 Changes to Sole Subsidised Supply ............................................................. 23 Delisted Items ............................................................................................. 24 Items to be Delisted .................................................................................... 25 Section H changes to Part II ........................................................................ 27 Index ........................................................................................................... 33

Summary of PharmaC decisions

effeCtive 1 JaNUarY 2010 New listings (page 18) • Mesalazine (Asamax) tab EC 500 mg • Pindolol (Apo-Pindolol) tab 5 mg, 10 mg and 15 mg • Silver sulphadiazine (Flamazine) crm 1% - up to 250 g available on a PSO and not in combination • Solifenacin succinate (Vesicare) tab 5 mg and 10 mg – Special Authority – Retail pharmacy • Flucloxacillin sodium (AFT) cap 250 mg and 500 mg • Paracetamol with codeine (ParaCode) tab paracetamol 500 mg with codeine phosphate 8 mg Changes to restrictions (page 19) • Somatropin (Genotropin) inj cartridge 16 iu per vial and 36 iu per vial – amended chemical name from growth hormone biosynthetic human • Somatropin (Norditropin SimpleXx) inj 5 mg, 10 mg and 15 mg – amended chemical name from recombinant human growth hormone • Cyclosporin (Neoral) cap 25 mg, 50 mg, 100 mg and oral liq 100 mg per ml – amended chemical name from cyclosporin A • Oral feed 1.5 kcal/ml (Ensure Plus) liquid (coffee latte) – amended presentation Decreased subsidy (pages 20-22) • Metformin hydrochloride (Arrow-Metformin) tab immediate-release 500 mg and 850 mg • Cholecalciferol (Cal-d-Forte) tab 1.25 mg (50,000 iu) • Hydrocortisone butyrate lipocream 0.1%, 30 g OP and 100 g OP (Locoid Lipocream); oint 0.1%, 100 g OP (Locoid); and milky emul 0.1%, 100 ml OP (Locoid Crelo); scalp lotn 0.1%, 100 ml OP (Locoid) • Hydrocortisone with natamycin and neomycin (Pimafucort) crm and oint 15 g OP • Mometasone furoate (Elocon) crm 0.1% and oint 0.1%, 15 g OP and 45 g OP • Cyproterone acetate with ethinyloestradiol (Estelle 35-ED) tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs • Medroxyprogesterone acetate (Provera) tab 5 mg, 10 mg, 100 mg and 200 mg • Medroxyprogesterone acetate (Depo-Provera) inj 150 mg per ml, 1 ml syringe • Somatropin (Genotropin) inj cartridge 16 iu per vial and 36 iu per vial • Carbergoline (Dostinex) tab 0.5 mg, 2 and 8 tab pack • Amoxycillin clavulanate (Augmentin) grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml and grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml

Summary of PharmaC decisions – effective 1 January 2010 (continued) • Clindamycin (Dalacin C) inj phosphate 150 mg per ml, 4 ml • Isoniazid (PSM) tab 100 mg • Etidronate disodium (Didronel and Etidrate) tab 200 mg • Codeine phosphate (PSM) tab 15 mg, 30 mg and 60 mg • Alprazolam (Arrow-Alprazolam) tab 250 µg, 500 µg and 1 mg • Dexamphatamine sulphate (PSM) tab 5 mg • Oxaliplatin (Baxter) inj 1 mg for ECP • Cyclosporin (Neoral) cap 25 mg, 50 mg, 100 mg and oral liq 100 mg per ml increased subsidy (pages 20-22) • Glycerol (PSM) suppos 3.6 g • Folic acid (Apo-Folic Acid) tab 0.8 mg and 5 mg • Medroxyprogesterone acetate (Provera) tab 2.5 mg • Pethidine hydrochloride (PSM) tab 50 mg and 100 mg • Phenobarbitone (PSM) tab 15 mg and 30 mg

Pharmaceutical Schedule - Update News

Solifenacin succinate tablets– new listing

Solifenacin succinate (Vesicare) 5 mg and 10 mg tablets will be listed with Special Authority criteria in the Pharmaceutical Schedule from 1 January 2010. Solifenacin succinate provides a subsidised alternative treatment for patients with overactive bladder syndrome intolerant to oxybutynin.

Mesalazine 500 mg enteric coated tablets – new listing

Mesalazine (Asamax) 500 mg enteric coated tablets will be listed without restrictions in the Pharmaceutical Schedule from 1 January 2010. Asamax provides a further treatment option for patients with Crohn’s disease and ulcerative colitis.

Silver sulphadiazine (Flamazine) 1% cream – new listing

Silver sulphadiazine (Flamazine) 1% cream will be listed in the Pharmaceutical Schedule from 1 January 2010. Flamazine will be a replacement for Silvazine (silver sulphadiazine cream 1% with 0.2% chlorhexidine digluconate) which Smith and Nephew is discontinuing once stock is exhausted. Flamazine will also be available on PSO for up to 250 g (five tubes of 50 g).

6 Pharmaceutical Schedule - Update News

Fosamax Plus

Please note that the new strength of Fosamax Plus (alendronate sodium 70 mg with cholecalciferol 5,600 iu) is able to be substituted for the other strength (alendronate sodium 70 mg with cholecalciferol 2,800 iu) for a patient with a prescription written for ‘Fosamax Plus’. However, if the patient is also prescribed another form of vitamin D (eg cholecalciferol tab 1.25 mg) pharmacists are advised to contact the prescriber to ensure they are aware of the increase in the cholecalciferol content in Fosamax Plus and to clarify whether or not the separate prescription for vitamin D supplementation is needed if the higher strength of Fosamax Plus is dispensed.

New risperidone and topiramate listings – update

The listing of Dr Reddy’s Risperidone (risperidone 1 mg, 2 mg, 3 mg and 4 mg tablets) has been delayed to 1 February 2010. The listing of Apo-Risperidone (risperidone 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg tablets and 1 mg per ml oral liquid) has been delayed and will no longer be listed from 1 January 2010. We will advise of the new listing date when this information becomes available. Arrow-Topiramate (topiramate 25 mg, 50 mg, 100 mg and 200 mg tablets) will be listed from 1 April 2010. Apo-Topiramate (topiramate 25 mg, 50 mg, 100 mg and 200 mg tablets) will not be listed from 1 January 2010. It is likely that the listing of Apo-Topiramate will not now occur. There has been no change to the listings of the Ridal and Risperdal brands of risperidone or the Topamax brand of topiramate.

Pharmaceutical Schedule - Update News

Colifoam – clarification of dose

The presentation description of Colifoam (hydrocortisone acetate rectal foam 10%, CFC-Free (14 applications)) was amended in October 2007 to alleviate confusion over the number of doses per pack. There still appears to be some confusion over the number of doses contained in each pack. Each 21.1 g OP contains 14 applications, not one single application. We believe that some prescribers are prescribing one original pack per dose as they are unsure of the number of doses per pack. When prescribing and dispensing this product we ask that the number of packs requested, and dispensed, are consistent with the dose instructions. Patients do not require one original pack per day.

Depo-Provera – glass vial delisting

Depo-Provera is currently listed in the Pharmaceutical Schedule under two different presentations, a prefilled syringe (pharmacode: 271691) and a glass vial (pharmacode: 2113929). The glass vial was originally listed to cover an out-of-stock situation in 2008, and Pfizer have not stocked this presentation since October 2008. The glass vial will be delisted from the Pharmaceutical Schedule from 1 January 2010. Please ensure all claims submitted from 1 January 2010 are for the prefilled syringe (Pharmacode: 271691).

tender News

Sole Subsidised Supply changes – effective 1 February 2010

Chemical Name Fluticasone proprionate Isotretinoin Isotretinoin Presentation; Pack size Metered aqueous nasal spray, 50 µg per dose; 120 dose OP Cap 10 mg; 180 cap Cap 20 mg; 180 cap Sole Subsidised Supply brand (and supplier) Flixonase Hayfever & Allergy (GSK) Oratane (Douglas) Oratane (Douglas)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for implementation 1 february 2010 • Anastrozole (Arimidex) tab 1 mg – subsidy decrease • Calcipotriol (Daivonex) crm 50 µg per g, 30 g OP and 100 g OP; oint 50 µg per g, 30 g OP and 100 g OP; and soln 50 µg per ml, 30 ml OP and 60 ml OP – price and subsidy decrease • Blood glucose diagnostic test meter (On Call Advanced) meter – new listing • Blood glucose diagnostic test strips (On Call Advanced) blood glucose test strip x 50 with lancets x 5 – new listing • Exemestane (Aromasin) tab 25 mg – subsidy decrease, and addition of Alternate Subsidy by Special Authority for patients receiving funded exemestane prior to 1 February 2010 and for patients with advanced breast cancer who have progressed following treatment with, or who are intolerant to, anastrozole or letrozole • Flecanide acetate (Tambocor and Tambocor CR) tab 50 mg & 100 mg; cap long-acting 100 mg & 200 mg – price and subsidy increase • Goserelin acetate (Zoladex) inj 3.6 mg and 10.8 mg – price and subsidy decrease • Influenza vaccine – amended access criteria • Letrozole (Letara) tab 2.5 mg – new listing • Methylphenidate hydrochloride extended-release (Ritalin LA) cap modifiedrelease 10 mg – new listing under existing Special Authority criteria • Metoprolol succinate (Betaloc CR) tab long-acting 23.75 mg, 47.5 mg, 95 mg and 190 mg – price and subsidy decrease • Pregnancy tests – HCG urine, cassette – removal of Only on a WSO and addition of Only on a PSO restriction

Looking forward – effective 1 february 2010 (continued) • Risperidone (Apo-Risperidone) tab 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg and oral liquid 1 mg per ml – new listing • Risperidone (Dr Reddy’s Risperidone) tab 1 mg, 2 mg, 3 mg and 4 mg – new listing • Sumatriptan (Arrow-Sumatriptan) tab 50 mg and 100 mg, 100 tab pack – new listing • Sumatriptan (Arrow-Sumatriptan) tab 50 mg, 4 tab pack; and 100 mg, 2 tab pack – price and subsidy decrease • Sumatriptan (Imigran and Sumagran) tab 50 mg and 100 mg – subsidy decrease

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Acarbose Acetazolamide Allopurinol Alprazolam Amantadine hydrochloride Amlodipine Amoxycillin

Presentation

Tab 50 mg & 100 mg Tab 250 mg Tab 100 mg & 300 mg Tab 250 µg, 500 µg & 1 mg Cap 100 mg Tab 5 mg & 10 mg Drops 125 mg per 1.25 ml Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg

Brand Name Expiry Date*

Glucobay Diamox Apo-Allopurinol Arrow-Alprazolam Symmetrel Apo-Amlodipine Ospamox Paediatric Drops Ibiamox Apo-Amoxi Synermox AFT Ethics Aspirin Ethics Aspirin EC Pacific Atenolol AstraZeneca Arrow-Azithromycin Pacifen Sandoz Beta Scalp Fibalip Bicalox Lax-Tabs AFT Marcain Isobaric Marcain Heavy healthE API Miacalcic Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy-Cefaclor Ranbaxy-Cefaclor Hospira Zinacef 2012 2011 2011 2010 2011 2011 2011 2010 2011 2011 2010 2012 2012 2012 2012 2011 2012 2011 2011 2010 2011 2010 2012 2011 2011 2011 2010 2010 2011 2011

Amoxycillin clavulanate Aqueous cream Aspirin Atenolol Atropine sulphate Azithromycin Baclofen Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcium Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium

Tab amoxycillin 500 mg with potassium clavulanate 125 mg Crm 500 g Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Tab 500 mg Tab 10 mg Inj 1 mega u Scalp app 0.1% Tab 200 mg Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Crm, aqueous, BP Lotn, BP Inj 100 iu per ml, 1 ml Tab eff 1 g Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 750 mg & 1.5 g

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate Ciclopiroxolamine Ciprofloxacin Citalopram Clarithromycin Clobetasol propionate

Presentation

Crm BP Tab 10 mg Oral liq 1 mg per ml Eye oint 1% Soln 4% Nail soln 8% Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Oint 0.05% Scalp app 0.05% Tab 500 µg & 2 mg TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Inj 150 µg per ml, 1 ml Tab 25 µg Tab 150 µg Crm 1% Vaginal crm 1% with applicator(s) Vaginal crm 2% with applicators(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg & 100 mg Inj 500 mg Nasal spray 10 µg per dose Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

PSM Zetop Cetirizine-AFT Chlorsig Orion Batrafen Rex Medical Arrow-Citalopram Klamycin Klacid Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Catapres Dixarit Catapres Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone Mayne Desmopressin-PH&T PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit 2010 2011 2012 2011 2012 2011 2011 2010 2012

Clonazepam Clonidine

2011 2012

Clonidine hydrochloride

2012

Clotrimazole

2010

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Desferrioxamine mesylate Desmopressin Dexamphetamine sulphate Dextrose Dextrose with electrolytes

2010 2010 2010 2010 2010 2012 2010 2012 2010 2011 2010 2011 2010

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Diclofenac sodium

Presentation

Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab 30 mg & 60 mg Cap long-acting 120 mg, 180 mg & 240 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Tab 400 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Tab long-acting 5 mg Tab long-acting 10 mg Oral liq 150 mg per 5 ml Tab 5 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Tab 40 mg

Brand Name Expiry Date*

Voltaren Ophtha Voltaren Voltaren Dilzem Cardizem CD Pytazen SR Apo-Doxazosin AFT Clexane Comtan E-Mycin E-Mycin E-Mycin NZ Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Felo 5 ER Felo 10 ER Ferodan Fintral AFT AFT Flucloxin Pacific Fludara Fludara Oral Ultraproct Ultraproct 2012 2010 2011 2012 2011 2011 2011 2010 2011

Diltiazem hydrochloride

2011

Dipyridamole Doxazosin mesylate Emulsifying ointment Enoxaparin sodium (low molecular weight heparin) Entacapone Erythromycin ethyl succinate

2011 2010 2011 2012 2012 2012 2011 2012 2010

Ethinyloestradiol Ethinyloestradiol with norethisterone

Felodipine Ferrous sulphate Finasteride Flucloxacillin sodium

Fluconazole Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

Fluoromethalone Fluoxetine hydrochloride Furosemide

FML Fluox Fluox Diurin 40

2012 2010 2012

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Fusidic acid Gabapentin Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Presentation

Crm 2% Oint 2% Cap 100 mg, 300 mg & 400 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 µg Oral pump spray 400 µg per dose TDDS 5 mg & 10 mg

Brand Name Expiry Date*

Foban Foban Nupentin Pfizer Apo-Gliclazide Minidiab Lycinate Nitrolingual Pumpspray Nitroderm TTS Serenace Serenace Douglas ABM PSM Colifoam Locoid DP Lotn HC Plaquenil Methopt Buscopan Gastrosoothe Ethics Ibuprofen Fenpaed Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Sporanox Sebizole Duphalac Betagan Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril 2012 2010 31/7/12 2012 2011 2011 2011

Haloperidol Hydrocortisone

Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Powder Crm 1% Rectal foam 10%, CFC-free (14 applications) Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Tab 200 mg Eye drops 0.5% Inj 20 mg, 1 ml Tab 20 mg Tab 200 mg Oral liq 100 mg per 5 ml Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg

2010 2012 2011 2012 2010 2011 2012 2011 2011 2012 2010 2010

Hydrocortisone acetate Hydrocortisone butyrate Hydrocortisone with wool fat and mineral oil Hydroxychloroquine sulphate Hypromellose Hysocine N-butylbromide Ibuprofen Ipratropium bromide

Iron polymaltose Itraconazole Ketoconazole Lactulose Levobunolol Lignocaine hydrochloride

2011 2010 2011 2010 2010 2010

Lignocaine with prilocaine

2010

Lisinopril

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Loperamide hydrochloride Loratadine

Presentation

Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Nodia Loraclear Hayfever Relief Lorapaed Derbac M A-Lices Foremount Child’s Silicone Mask De-Worm Colofac Provera Pentasa Biodone Biodone Forte Biodone Extra Forte Methatabs Methoblastin Methotrexate Ebewe Methotrexate Ebewe Prodopa Medrol Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Multichem RA-Morph RA-Morph RA-Morph RA-Morph Sevredol Mayne Mayne Apo-Nadolol ReVia 2010 2010

Malathion Mask for Spacer Device Mebendazole Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Methadone hydrochloride

Liq 0.5% Shampoo 1% Device Tab 100 mg Tab 135 mg Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg Tab 2.5 mg & 10 mg Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 125 mg, 250 mg & 500 mg Tab 4 mg & 100 mg Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Inj 5 mg per ml, 2 ml Crm 2% Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab immediate release 10 mg & 20 mg Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab 40 mg & 80 mg Tab 50 mg

2010 2011 30/9/11 2011 2011 2010 2012 2012 2010 2012 2011 2011 2012 2011 2011 2012

Methotrexate

Methyldopa Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

Metoclopramide hydrochloride Miconazole nitrate Morphine hydrochloride

2011 2011 2012

Morphine sulphate

2012 2011 2010 2010

Nadolol Naltrexone hydrochloride

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Naproxen Naproxen sodium Neostigmine Nevirapine

Presentation

Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 200 mg

Brand Name Expiry Date*

Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Viramune Habitrol Habitrol Habitrol Habitrol Noriday 28 Primolut N Norpress Nilstat Nilstat Nilstat Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Pantocid IV Dr Reddy’s Pantoprazole Pharmacare Paracare Junior Paracare Double Strength Lacri-Lube Loxamine 2012 2010 2010 2012

Nicotine

Patch 7 mg, 14 mg & 21 mg Lozenge 1 mg & 2 mg Gum 2 mg & 4 mg (Fruit) Gum 2 mg & 4 mg (Mint) Tab 350 µg Tab 5 mg Tab 10 mg & 25 mg Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Cap 10 mg, 20 mg & 40 mg Inj 40 mg

2010

Norethisterone Nortriptyline hydrochloride Nystatin

2012 2011 2011 2011 2010 2011

Omeprazole

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml & 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Inj 40 mg Tab 20 mg & 40 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Eye oint with soft white paraffin Tab 20 mg

2010 2010 2010 2012

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

2011

Paraffin liquid with soft white paraffin Paroxetine hydrochloride

2010 2010

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Peak Flow Meter Pergolide Phenoxymethylpenicillin (Penicillin V) Phenylephrine hydrochloride Pioglitazone Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone Prednisone sodium phosphate Procaine penicillin Promethazine Quinapril Quinapril with hydroclorothiazide

Presentation

Low range and Normal range Tab 0.25 mg & 1 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg & 500 mg Eye drops 0.12% Tab 15 mg, 30 mg & 45 mg Oral drops 10% Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg, 2.5 mg, 5 mg & 20 mg Oral liq 5 mg per ml Inj 1.5 mega u Tab 10 mg & 25 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 0.25 mg, 1 mg, 2 mg and 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratopium bromide 0.5 mg per vial, 2.5 ml Tab 5 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Grans eff 4 g sachets Nasal spray, 4%

Brand Name Expiry Date*

Breath-Alert Permax AFT AFT Cilicaine VK Prefrin Pizaccord Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Redipred Cilicaine Allersoothe Accupril Accuretic 10 Accuretic 20 Q 300 Peptisoothe Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Salapin Duolin 2012 2010 2010 2010 2012 2012 2010 2012 30/9/11 2011 2010

2010 2012 2011 2011 2012 2010 2011 2012 2011 2011 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Ropinirole hydrochloride Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Simvastatin

Apo-Selegiline Arrow-Simva 10 mg Arrow-Simva 20 mg Arrow-Simva 40 mg Arrow-Simva 80 mg Ural Rex

2012 2011

Sodium citro-tartrate Sodium cromoglycate

2010 2012

Sole Subsidised Supply Products – cumulative to January 2010

Generic Name

Sotalol Spacer Device Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terazosin hydrochloride Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate Triamcinolone acetonide

Presentation

Tab 80 mg & 160 mg 230 ml Liq Soln 2.3% Tab 10 mg Tab 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 µg Inj 1 mg per ml, 1 ml Tab 10 mg Eye drops 0.25% & 0.5% Crm 0.02% Oint 0.02% Inj 40 mg per ml, 1 ml 0.1% in Dental Paste USP Tab 300 mg Cap 300 mg Inj 50 mg per ml, 10 ml Oint BP Cap 220 mg Tab 7.5 mg

Brand Name Expiry Date*

Mylan Space Chamber Midwest Pinetarsol Normison Apo-Terazosin Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timol Apo-Timop Aristocort Aristocort Kenacort-A40 Oracort TMP Actigall Pacific PSM Zincaps Apo-Zopiclone 2012 30/9/11 2010 2011 2011 2010 2011 2011 2011 2012 2011 2011

Trimethoprim Ursodeoxycholic acid Vancomycin hydrochloride Zinc and castor oil Zinc sulphate Zopiclone January changes in bold

2011 2011 2011 2011 2011 2011

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 January 2010

26 52 59 MESALAZINE Tab EC 500 mg ...................................................................... 49.50 PINDOLOL ❋ Tab 5 mg ................................................................................. 5.40 ❋ Tab 10 mg ............................................................................... 9.19 ❋ Tab 15 mg ............................................................................. 13.80 SILVER SULPHADIAZINE Crm 1% .................................................................................. 12.30 a) Up to 250 g available on a PSO b) Not in combination 100 100 100 100 50 g OP ✔ Asamax ✔ Apo-Pindolol ✔ Apo-Pindolol ✔ Apo-Pindolol ✔ Flamazine

SOLIFENACIN SUCCINATE – Special Authority see SA0998 – Retail pharmacy Tab 5 mg ................................................................................ 56.50 30 ✔ Vesicare Tab 10 mg .............................................................................. 56.50 30 ✔ Vesicare ➽ SA0998 Special Authority for Subsidy Initial application from any relevant practitioner. Applications valid without further renewal unless notified for applications where the patient has overactive bladder and a documented intolerance of oxybutynin. FLUCLOXACILLIN SODIUM Cap 250 mg – Up to 30 cap available on a PSO ....................... 32.00 Cap 500 mg ......................................................................... 110.00 PARACETAMOL WITH CODEINE ❋ Tab paracetamol 500 mg with codeine phosphate 8 mg ............. 2.45 250 500 100 ✔ AFT ✔ AFT ✔ ParaCode

112

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 January 2010

79 80 149 SOMATROPIN GROWTH HORMONE BIOSYNTHETIC HUMAN – Special Authority see SA0755 ❋ Inj cartridge 16 iu per vial ..................................................... 249.60 1 ✔ Genotropin 1,248.00 5 ✔ Genotropin ❋ Inj cartridge 36 iu per vial ..................................................... 561.60 1 ✔ Genotropin 2,808.00 5 ✔ Genotropin SOMATROPIN RECOMBINANT HUMAN GROWTH HORMONE – Special Authority see SA0755 ❋ Inj 5 mg ............................................................................... 300.00 1 ✔ Norditropin SimpleXx 5mg ❋ Inj 10 mg ............................................................................. 600.00 1 ✔ Norditropin SimpleXx 10mg ❋ Inj 15 mg ............................................................................. 900.00 1 ✔ Norditropin SimpleXx 15mg CYCLOSPORIN A – Hospital pharmacy [HP3] Cap 25 mg ............................................................................. 59.50 50 Cap 50 mg ........................................................................... 118.54 50 Cap 100 mg ......................................................................... 237.08 50 Oral liq 100 mg per ml .......................................................... 264.17 50 ml OP Note – change in chemical name from cyclosporin A to cyclosporin only. ✔ Neoral ✔ Neoral ✔ Neoral ✔ Neoral

179

ORAL FEED 1.5KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid (coffee latte) .................................................................. 1.33 237 ml OP ✔ Ensure Plus

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 January 2010

30 METFORMIN HYDROCHLORIDE ( subsidy) ❋ Tab immediate-release 500 mg.................................................. 8.09 ❋ Tab immediate-release 850 mg.................................................. 6.67 GLYCEROL ( subsidy) ❋ Suppos 3.6 g – Only on a prescription ....................................... 6.00 CHOLECALCIFEROL ( subsidy) ❋ Tab 1.25 mg (50,000 iu) – Maximum of 12 tab per prescription........................................ 7.76 FOLIC ACID ( subsidy) ❋ Tab 0.8 mg ............................................................................ 19.80 ❋ Tab 5 mg ............................................................................... 10.21 HYDROCORTISONE BUTYRATE ( subsidy) Lipocream 0.1% ........................................................................ 2.30 6.85 Oint 0.1% .................................................................................. 6.85 Milky emul 0.1% ........................................................................ 6.85 500 250 20 ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ PSM

34 37

12 1,000 500 30 g OP 100 g OP 100 g OP 100 ml OP

✔ Cal-d-Forte ✔ Apo-Folic Acid ✔ Apo-Folic Acid ✔ Locoid Lipocream ✔ Locoid Lipocream ✔ Locoid ✔ Locoid Crelo

HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN – Only on a prescription ( subsidy) Crm 1% with natamycin 1% and neomycin sulphate 0.5% .......... 2.79 15 g OP ✔ Pimafucort Oint 1% with natamycin 1% and neomycin sulphate 0.5% .......... 2.79 15 g OP ✔ Pimafucort MOMETASONE FUROATE ( subsidy) Crm 0.1% .................................................................................. 2.38 4.55 Oint 0.1% .................................................................................. 2.38 4.55 WOOL FAT WITH MINERAL OIL – Only on a prescription ( price) ❋ Lotn hydrous 3% with mineral oil ............................................... 1.40 (3.50) HYDROCORTISONE BUTYRATE ( subsidy) Scalp lotn 0.1% ......................................................................... 3.65 MEDROXYPROGESTERONE ACETATE ( subsidy) ❋ Inj 150 mg per ml, 1 ml syringe – Up to 5 inj available on a PSO ............................................. 7.15 CYPROTERONE ACETATE WITH ETHINYLOESTRADIOL ( subsidy) ❋ Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs ............... 4.91 (6.30) MEDROXYPROGESTERONE ACETATE ❋ Tab 2.5 mg ( subsidy) ............................................................. 3.09 ❋ Tab 5 mg ( subsidy) .............................................................. 13.06 ❋ Tab 10 mg ( subsidy) .............................................................. 6.85 15 g OP 45 g OP 15 g OP 45 g OP 250 ml OP Hydroderm Lotion 100 ml OP ✔ Locoid ✔ Elocon ✔ Elocon ✔ Elocon ✔ Elocon

66 72

1 84

✔ Depo-Provera

Estelle 35-ED 30 100 30 ✔ Provera ✔ Provera ✔ Provera

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

79 MEDROXYPROGESTERONE ACETATE ( subsidy) ❋ Tab 100 mg – Retail pharmacy – Specialist ............................. 96.50 ❋ Tab 200 mg – Retail pharmacy – Specialist ............................. 70.50 SOMATROPIN – Special Authority see SA0755 ( subsidy) ❋ Inj cartridge 16 iu per vial ...................................................... 249.60 1,248.00 ❋ Inj cartridge 36 iu per vial ...................................................... 561.60 2,808.00 CABERGOLINE ( subsidy) Tab 0.5 mg – Maximum of 2 tab per prescription; can be waived by Special Authority see SA0175 .................. 16.50 66.00 AMOXYCILLIN CLAVULANATE ( subsidy) Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 2.20 (2.75) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 3.85 (4.75) CLINDAMYCIN ( subsidy) Inj phosphate 150 mg per ml, 4 ml – Retail pharmacy – Specialist............................................................................. 16.00 ISONIAZID – Retail pharmacy – Specialist ( subsidy) No patient co-payment payable ❋ Tab 100 mg ............................................................................ 20.00 ETIDRONATE DISODIUM ( subsidy) ❋ Tab 200 mg ............................................................................ 14.37 (22.80) 23.95 QUININE SULPHATE ( price) ❋ Tab 200 mg ............................................................................ 15.95 (17.20) ‡ Safety cap for extemporaneously compounded oral liquid preparations. CODEINE PHOSPHATE ( subsidy) Tab 15 mg ................................................................................ 5.39 Tab 30 mg ................................................................................ 8.25 Tab 60 mg .............................................................................. 17.76 PETHIDINE HYDROCHLORIDE ( subsidy) a) Only on a controlled drug form b) No patient co-payment payable Tab 50 mg ................................................................................ 3.20 Tab 100 mg .............................................................................. 4.20 100 30 1 5 1 5 ✔ Provera ✔ Provera ✔ Genotropin ✔ Genotropin ✔ Genotropin ✔ Genotropin

2 8

✔ Dostinex ✔ Dostinex

100 ml Augmentin 100 ml Augmentin

✔ Dalacin C

100 60 100 250

✔ PSM

108

Didronel ✔ Etidrate

109

Q 200

111

100 100 100

✔ PSM ✔ PSM ✔ PSM

113

10 10

✔ PSM ✔ PSM

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

118 PHENOBARBITONE ( subsidy) ❋ Tab 15 mg .............................................................................. 25.00 ❋ Tab 30 mg .............................................................................. 26.00 ALPRAZOLAM – Month Restriction ( subsidy) Tab 250 µg .............................................................................. 3.15 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 500 µg .............................................................................. 4.10 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 1 mg .................................................................................. 7.25 ‡ Safety cap for extemporaneously compounded oral liquid preparations. 500 500 50 50 50 ✔ PSM ✔ PSM ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam

127

131

DEXAMPHETAMINE SULPHATE – Special Authority see SA0907 – Retail pharmacy ( subsidy) Only on a controlled drug form Tab 5 mg ................................................................................ 16.50 100 ✔ PSM OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 ( subsidy) Inj 1 mg for ECP ........................................................................ 1.42 1 mg CYCLOSPORIN – Hospital pharmacy [HP3] ( subsidy) Cap 25 mg .............................................................................. 59.50 Cap 50 mg ............................................................................ 118.54 Cap 100 mg .......................................................................... 237.08 Oral liq 100 mg per ml ........................................................... 264.17 50 50 50 50 ml OP ✔ Baxter ✔ Neoral ✔ Neoral ✔ Neoral ✔ Neoral

136 149

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Sole Subsidised Supply

Effective 1 January 2010

For the list of new Sole Subsidised Supply products effective 1 January 2010 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 10-17.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 January 2010

60 CALAMINE a) Only on a prescription b) Not in combination Crm, aqueous, BP ..................................................................... 2.78 (3.02) Lotn, BP .................................................................................. 16.70 (19.44) MEDROXYPROGESTERONE ACETATE ❋ Inj 150 mg per ml, 1 ml – Up to 5 inj available on a PSO ............ 8.05 CO-TRIMOXAZOLE ❋ Oral liq sugar-free trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml – Up to 200 ml available on a PSO............... 5.90 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab long-acting 6 mg ................................................................ 2.70 (7.73) 5.40 (12.56) PILOCARPINE ❋ Eye drops 2% ............................................................................ 4.32

100 g ABM 2,000 ml ABM 1 ✔ Depo-Provera

72 86

500 ml 20

✔ Trisul

151

Polaramine Repetab 40 Polaramine Repetab 15 ml OP

160

✔ Pilopt

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 April 2010

30 METFORMIN HYDROCHLORIDE ❋ Tab immediate-release 500 mg.................................................. 8.09 ❋ Tab immediate-release 850 mg.................................................. 6.67 MOMETASONE FUROATE Crm 0.1% .................................................................................. 2.38 4.55 Oint 0.1% .................................................................................. 2.38 4.55 CYPROTERONE ACETATE WITH ETHINYLOESTRADIOL ❋ Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs ............... 4.91 (6.30) AMOXYCILLIN CLAVULANATE Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 2.20 (2.75) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 3.85 (4.75) ETIDRONATE DISODIUM ❋ Tab 200 mg ............................................................................ 14.37 (22.80) 23.95 500 250 15 g OP 45 g OP 15 g OP 45 g OP 84 Estelle 35-ED ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ Elocon ✔ Elocon ✔ Elocon ✔ Elocon

100 ml Augmentin 100 ml Augmentin 60 100 Didronel ✔ Etidrate

108

Effective 1 July 2010

59 SILVER SULPHADIAZINE Crm 1% with chlorhexidine digluconate 0.2% ........................... 15.04 a) Up to 500 g available on a PSO b) Not in combination HYDROCORTISONE BUTYRATE Milky emul 0.1% ........................................................................ 5.00 DITHRANOL Crm 1% ................................................................................... 27.50 100 g OP ✔ Silvazine

62 65

30 ml OP 50 g OP

✔ Locoid Crelo ✔ Micanol

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 July 2010 (continued)

80 SOMATROPIN – Special Authority see SA0755 ❋ Inj 5 mg ................................................................................ 300.00 ❋ Inj 10 mg .............................................................................. 600.00 ❋ Inj 15 mg .............................................................................. 900.00 138 FLUDARABINE PHOSPHATE – PCT only – Specialist Tab 10 mg ........................................................................... 650.25 1 1 1 ✔ Norditropin SimpleXx 5 mg ✔ Norditropin SimpleXx 10 mg ✔ Norditropin SimpleXx 15 mg ✔ Fludara

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 January 2010

CHOLECALCIFEROL ( price) Tab 50,000 iu .................................Cal-d-Forte CLINDAMYCIN ( price) Inj phosphate 150 mg per ml, 4 ml ...........................................Dalacin C CODEINE PHOSPHATE ( price) Tab 15 mg......................................PSM Tab 30 mg......................................PSM Tab 60 mg......................................PSM CYCLOSPORIN ( price) Cap 25 mg ....................................Neoral Cap 50 mg ....................................Neoral Cap 100 mg ...................................Neoral Oral liq 100 mg per ml ...................Neoral DEXAMPHETAMINE SULPHATE ( price) Tab 5 mg........................................PSM ERYTHROPOIETIN BETA ( price) Inj 2,000 iu prefilled syringe ............NeoRecormon Inj 3,000 iu prefilled syringe ............NeoRecormon Inj 4,000 iu prefilled syringe ............NeoRecormon Inj 5,000 iu prefilled syringe ............NeoRecormon Inj 6,000 iu prefilled syringe ............NeoRecormon Inj 10,000 iu prefilled syringe ..........NeoRecormon 7.76 12

16.00 5.39 8.25 17.76 59.50 118.54 237.08 264.17 16.50 120.18 166.87 193.13 243.26 291.92 395.18

1 100 100 100 50 50 50 50 ml 100 6 6 6 6 6 6 1% 1% Mar-10 Mar-10 Staphlex Staphlex 1% Apr-08 (B) 1% 1% 1% Mar-08 Mar-08 Mar-08 (B) (B) (B)

FLUCLOXACILLIN SODIUM Cap 250 mg ...................................AFT 32.00 250 Cap 500 mg ...................................AFT 110.00 500 Note – Staphlex cap 250 mg and 500 mg to be delisted 1 March 2010. GADOBUTROL Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5 ml prefilled syringe ......................................Gadovist GADODIAMIDE Inj 287 mg per ml, 10 ml ................Omniscan Inj 287 mg per ml, 15 ml ................Omniscan Inj 287 mg per ml, 10 ml pre-filled syringe ......................................Omniscan Inj 287 mg per ml, 15 ml pre-filled syringe ......................................Omniscan Inj 287 mg per ml, 20 ml pre-filled syringe ......................................Omniscan

253.10 180.00 270.00 220.00 330.00 440.00

5 10 10 10 10 10

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

GLYCEROL ( price) Suppos 3.6 g..................................PSM 6.00 20

HEPARINISED SALINE Inj 100 iu per ml, 5 ml ....................Mayne 103.76 50 Note – Mayne’s brand of heparinised saline inj 100 iu per ml, 5 ml to be delisted 1 March 2010. HYDROCORTISONE Crm 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort Oint 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort HYDROCORTISONE BUTYRATE (new listing) Scalp lotn 0.1% ..............................Locoid HYDROCORTISONE BUTYRATE ( price) Lipocream 0.1% ............................Locoid Lipocream Lipocream 0.1% ............................Locoid Lipocream Milky emulsion 0.1% .....................Locoid Crelo Oint 0.1% (brand name change)......Locoid Ointment IODIXANOL (new listing) Inj 320 mg per ml (iodine equivalent), 150 ml .........Visipaque Inj 320 mg per ml (iodine equivalent), 200 ml .........Visipaque IODIXANOL ( price and addition of HSS) Inj 270 mg per ml (iodine equivalent), 50 ml ...........Visipaque Inj 270 mg per ml (iodine equivalent), 100 ml .........Visipaque Inj 320 mg per ml (iodine equivalent), 50 ml ...........Visipaque Inj 320 mg per ml (iodine equivalent), 100 ml .........Visipaque IODIXANOL (addition of HSS) Inj 320 mg per ml (iodine equivalent), 200 ml .........Visipaque

2.79 2.79 3.65 2.30 6.85 6.85 6.85

15 g 15 g 100 ml 30 g 100 g 100 ml 100 g

670.50 894.00

10 10

5% 5%

Apr-10 Apr-10

(B) (B)

223.50 447.00 223.50 447.00

10 10 10 10

5% 5% 5% 5%

Apr-10 Apr-10 Apr-10 Apr-10

(B) (B) (B) (B)

565.56

Apr-10

(B)

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

IOHEXOL ( price and addition of HSS) Inj 240 mg per ml (iodine equivalent), 50 ml ......................Omnipaque 77.80 10 5% Apr-10 Iomeron Isovue 50 ml & 100 ml Opitray Ultravist Iomeron Isovue Optiray 20 ml & 30 ml Ultravist Iomeron Isovue Optiray Ultraject 50 ml & 75 ml Ultravist Iomeron Isovue Optiray 100 ml, 150 ml & 200 ml Ultraject 125 ml Ultravist (B) Iomeron Isovue Optiray 20 ml & 30 ml Ultraject 30 ml Ultravist 30 ml Iomeron Isovue Optiray Ultraject Ultravist Iomeron Optiray Ultraject Iomeron Isovue Optiray Ultraject 100 ml & 125 ml Ultravist continued...

Inj 300 mg per ml (iodine equivalent), 20 ml ......................Omnipaque

24.00

Apr-10

Inj 300 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

77.80

Apr-10

Inj 300 mg per ml (iodine equivalent), 100 ml ....................Omnipaque

155.60

Apr-10

Inj 300 mg per ml (iodine equivalent), 500 ml ....................Omnipaque Inj 350 mg per ml (iodine equivalent), 20 ml ......................Omnipaque

468.00 24.00

6 6

5% 5%

Apr-10 Apr-10

Inj 350 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

77.80

Apr-10

Inj 350 mg per ml (iodine equivalent), 75 ml ......................Omnipaque Inj 350 mg per ml (iodine equivalent), 100 ml ....................Omnipaque

116.70

Apr-10

155.60

Apr-10

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

continued... Inj 350 mg per ml (iodine equivalent), 200 ml .........................Omnipaque

Section H changes to Part II - effective 1 January 2010 (continued)

186.70 6 5% Apr-10 Iomeron Isovue Optiray Ultravist (B)

Inj 350 mg per ml (iodine equivalent), 500 ml ....................Omnipaque ISONIAZID ( price) Tab 100 mg....................................PSM MEDROXYPROGESTERONE ACETATE Inj 150 mg per ml, 1 ml, syringe (new listing)...................Depo-Provera Tab 2.5 mg ( price).......................Provera Tab 5 mg ( price)..........................Provera Tab 10 mg ( price)........................Provera Tab 100 mg ( price)......................Provera Tab 200 mg ( price)......................Provera

780.00 20.00

10 100

Apr-10

7.15 3.09 13.06 6.85 96.50 70.50

1 30 100 30 100 30

1% 1% 1% 1% 1%

Sept-07 Sept-07 Sept-07 Sept-07 Sept-07

Cycrin Cycrin Cycrin (B) (B)

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml ...........................Gastrografin 21.00 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml vial ......Magnevist MESALAZINE Tab EC 500 mg ..............................Asamax PETHIDINE HYDROCHLORIDE ( price) Tab 50 mg......................................PSM Tab 100 mg....................................PSM PHENOBARBITONE Tab 15 mg......................................PSM Tab 30 mg......................................PSM PINDOLOL Tab 5 mg........................................Apo-Pindolol Tab 10 mg......................................Apo-Pindolol Tab 15 mg......................................Apo-Pindolol QUININE SULPHATE ( price) Tab 200 mg....................................Q 200

184.00 49.50 3.20 4.20 25.00 26.00 5.40 9.19 13.80 17.20

10 100 10 10 500 500 100 100 100 250 1% 1% 1% Mar-10 Mar-10 Mar-10 Pindol Pindol Pindol

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

RECOMBINANT FACTOR VIII Inj 250 IU .......................................Xyntha 225.00 1 Inj 500 IU .......................................Xyntha 450.00 1 Inj 1,000 IU ....................................Xyntha 900.00 1 Inj 2,000 IU ....................................Xyntha 1,800.00 1 Note – Refacto brand of recombinant factor VIII inj 250 iu, 500 iu, 1,000 iu and 2,000 iu to be delisted 1 April 2010. SILVER SULPHADIAZINE Crm 1% ..........................................Flamazine SOLIFENACIN SUCCINATE Tab 5 mg........................................Vesicare Tab 10 mg......................................Vesicare TROPISETRON (addition of HSS) Cap 5 mg .......................................Navoban 12.30 56.50 56.50 77.41 50 g 30 30 5 1% Mar-10 (B)

Effective 1 December 2009

AMOXYCILLIN Grans for oral liq 125 mg per 5 ml ..Ospamox Grans for oral liq 250 mg per 5 ml .Ospamox ATROPINE SULPHATE ( price and discontinuing HSS) Eye drops 1% ................................Atropt 1.55 1.10 100 ml 100 ml

Feb-10

Amoxil Ranbaxy Amoxicillin (B)

17.36

15 ml

Dec-08

ATROPINE SULPHATE Inj 1200 µg, 1 ml............................AstraZeneca 32.00 50 Note – AstraZeneca inj 1200 µg, 1 ml to be delisted 1 February 2010. BLEOMYCIN SULPHATE Inj 15,000 iu ...................................Blenoxane 680.00 Note – Blenoxane inj 15,000 iu to be delisted 1 February 2010. CALCITRIOL Cap 0.25 µg ..................................Airflow Cap 0.5 µg .....................................Airflow 3.03 5.62 10

30 30

1% 1%

Feb-10 Feb-10

Calcitriol-AFT Rocaltrol Caltriol-AFT Rocaltrol

Note – Calcitriol-AFT cap 0.25 µg and 0.5 µg to be delisted 1 February 2010. CEPHALEXIN MONOHYDRATE Grans for oral liq 125 mg per 5 ml ..Cefalexin Sandoz Grans for oral liq 250 mg per 5 ml ..Cefalexin Sandoz 8.50 11.50 100 ml 100 ml 1% 1% Feb-10 Feb-10 (B) (B)

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 December 2009 (continued)

DOCETAXEL Inj 20 mg........................................Docetaxel 325.00 1 Ebewe Inj 80 mg........................................Docetaxel 1,300.00 1 Ebewe Note – Taxotere inj 20 mg and 80 mg to be delisted 1 February 2010. ETHAMBUTOL HYDROCHLORIDE Tab 100 mg....................................Myambutol FUROSEMIDE Tab 500 mg....................................Urex Forte 57.81 50.00 56 50 1% Sept-08 Pentaspan 1% 1% Feb-10 Feb-10 Docetaxel Winthrop Taxotere Docetaxel Winthrop Taxotere

HYDROXYETHYL STARCH 200/0.5 PENTASTARCH (amended description) Inj Inf 10% per 500 ml bag ..............StarQuin 10% 216.00 16 LETROZOLE ( price) Tab 2.5 mg.....................................Femara 146.46 30

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE ( price) Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml ...........................Gastrografin 210.00 10 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml prefilled Syringe ( price) ........................Magnevist 92.00 5 Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 20 ml ............Magnevist 33.85 1 Note – Magnevist inj 469 mg per ml, 20 ml to be delisted 1 February 2010. PERMETHRIN Lotn 5% .........................................A-Scabies Note – Lyderm crm 5% to be delisted 1 February 2010. 3.65 30 ml 1% Feb-10 Lyderm

POLYETHYLENE GLYCOL WITH SODIUM SULPHATE ( price) Powder, sachets .............................Klean-Prep 16.46 QUETIAPINE ( price) Tab 25 mg......................................Quetapel Tab 100 mg....................................Quetapel Tab 200 mg....................................Quetapel Tab 300 mg ...................................Quetapel 16.78 32.59 56.70 95.40

4 90 90 90 90

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A Airflow ............................................................... 31 Alprazolam ......................................................... 22 Amoxycillin ........................................................ 31 Amoxycillin clavulanate ................................ 21, 25 Apo-Folic Acid ................................................... 20 Apo-Pindolol ................................................ 18, 30 Arrow-Alprazolam .............................................. 22 Arrow-Metformin.......................................... 20, 25 Asamax ....................................................... 18, 30 A-Scabies .......................................................... 32 Atropine sulphate ............................................... 31 Atropt ................................................................ 31 Augmentin ................................................... 21, 25 B Blenoxane .......................................................... 31 Bleomycin sulphate ............................................ 31 C Cabergoline........................................................ 21 Cal-d-Forte................................................... 20, 27 Calamine............................................................ 24 Calcitriol ............................................................ 31 Cefalexin Sandoz ................................................ 31 Cephalexin monohydrate .................................... 31 Cholecalciferol ............................................. 20, 27 Clindamycin ................................................. 21, 27 Co-trimoxazole ................................................... 24 Codeine phosphate ...................................... 21, 27 Cyclosporin.................................................. 22, 27 Cyclosporin A .................................................... 19 Cyproterone acetate with ethinyloestradiol .... 20, 25 D Dalacin C ..................................................... 21, 27 Depo-Provera ......................................... 20, 24, 30 Dexamphetamine sulphate............................ 22, 27 Dextrochlorpheniramine maleate ......................... 24 Didronel ............................................................. 21 Docetaxel ........................................................... 32 Dithranol ............................................................ 25 Docetaxel Ebewe ................................................ 32 Dostinex ............................................................ 21 E Elocon ......................................................... 20, 25 Ensure Plus........................................................ 19 Erythropoietin beta ............................................. 27 Estelle 35-ED ............................................... 20, 25 Ethambutol hydrochloride ................................... 32 Etidrate ........................................................ 21, 25 Etidronate disodium ..................................... 21, 25 F Femara .............................................................. 32 Flamazine..................................................... 18, 31 Flucloxacillin sodium .................................... 18, 27 Fludara............................................................... 26 Fludarabine phosphate ....................................... 26 Folic acid ........................................................... 20 Furosemide ........................................................ 32 G Gadobutrol ......................................................... 27 Gadodiamide...................................................... 27 Gadovist ............................................................ 27 Gastrografin ................................................. 30, 32 Genotropin ................................................... 19, 21 Glycerol ....................................................... 20, 28 Growth hormone biosynthetic human ................. 19 H Heparinised saline .............................................. 28 Hydrocortisone .................................................. 28 Hydrocortisone butyrate ......................... 20, 25, 28 Hydrocortisone with natamycin and neomycin .... 20 Hydroderm Lotion .............................................. 20 Hydroxyethyl starch 200/0.5 .............................. 32 I Iodixanol ............................................................ 28 Iohexol ............................................................... 29 Isoniazid ...................................................... 21, 30 K Klean-Prep ......................................................... 32 L Letrozole ............................................................ 32 Locoid ......................................................... 20, 28 Locoid Crelo .......................................... 20, 25, 28 Locoid Lipocream ........................................ 20, 28 Locoid Ointment................................................. 28 M Magnevist .................................................... 30, 32 Medroxyprogesterone acetate........... 20, 21, 24, 30 Meglumine diatrizoate with sodium amidotrizoate ............................................ 30, 32 Meglumine gadopentetate............................. 30, 32 Mesalazine ................................................... 18, 30 Metformin hydrochloride .............................. 20, 25 Micanol.............................................................. 25 Mometasone furoate .................................... 20, 25 Myambutol......................................................... 32 N Navoban ............................................................ 31 Neoral .................................................... 19, 22, 27 NeoRecormon .................................................... 27 Norditropin SimpleXx 5 mg ........................... 19, 26 Norditropin SimpleXx 10 mg ......................... 19, 26 Norditropin SimpleXx 15 mg ......................... 19, 26 O Omnipaque .................................................. 29, 30

Index

Pharmaceuticals and brands Omniscan .......................................................... 27 Oral feed 1.5kcal/ml ........................................... 19 Ospamox ........................................................... 31 Oxaliplatin .......................................................... 22 P Paracetamol with codeine .................................. 18 ParaCode ........................................................... 18 Pentastarch........................................................ 32 Permethrin ......................................................... 32 Pethidine hydrochloride ................................ 21, 30 Phenobarbitone ............................................ 22, 30 Pilocarpine ......................................................... 24 Pilopt ................................................................. 24 Pimafucort ................................................... 20, 28 Pindolol ....................................................... 18, 30 Polaramine Repetab ........................................... 24 Polyethylene glycol with sodium sulphate ........... 32 Provera .................................................. 20, 21, 30 Q Q 200 .......................................................... 21, 30 Quetapel ............................................................ 32 Quetiapine.......................................................... 32 Quinine sulphate .......................................... 21, 30 R Recombinant factor viii....................................... 31 Recombinant human growth hormone ................ 19 S Silvazine ............................................................ 25 Silver sulphadiazine ................................ 18, 25, 31 Solifenacin succinate ................................... 18, 31 Somatropin ............................................ 19, 21, 26 StarQuin 10% ..................................................... 32 T Trisul ................................................................. 24 Tropisetron ........................................................ 31 U Urex Forte .......................................................... 32 V Vesicare....................................................... 18, 31 Visipaque ........................................................... 28 W Wool fat with mineral oil ..................................... 20 X Xyntha ............................................................... 31

Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Metadata

Title

Schedule Update - effective 1 January 2010

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January 2010 Section H cumulative for December 2009 and January 2010 Contents Summary of PHARMAC decisions effective 1 January 2010 … 3 Solifenacin succinate tablets– new listing ….. 5 Mesalazine…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.